FABP7 expression in glioblastomas: Relation to prognosis, invasion and EGFR status

Journal of Neuro-Oncology

Volumn 84, Issue 3, 2007, Pages 245-248

  Kaloshi, Gentian ^a   Mokhtari, Karima ^a,b   Carpentier, Catherine ^b   Taillibert, Sophie ^a   Lejeune, Julie ^a   Marie, Yannick ^b   Delattre, Jean Yves ^a,b   Godbout, Roseline ^c   Sanson, Marc ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

EGFR; FABP7; GBMO; Glioblastoma; Invasion

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROTEIN FABP7; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTE; CANCER INVASION; CANCER SURVIVAL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OLIGODENDROGLIA; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; BRAIN NEOPLASMS; CARRIER PROTEINS; CELL NUCLEUS; CYTOPLASM; FEMALE; GENE AMPLIFICATION; GLIOBLASTOMA; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 34547182884     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9377-4     Document Type: Article

References (11)

1. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO, Israel MA (2005) Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci USA 102:5814-5819
2. Feng L, Hatten ME, Heintz N (1994) Brain lipid-binding protein (BLBP): A novel signaling system in the developing mammalian CNS. Neuron 12:895-908
3. Liang Y, Bollen AW, Aldape KD, Gupta N (2006) Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. BMC Cancer 6:97
4. Godbout R, Bisgrove DA, Shkolny D, Day RS 3rd (1998) Correlation of B-FABP and GFAP expression in malignant glioma. Oncogene 16:1955-1962
5. Liang Y, Bollen AW, Nicholas MK, Gupta N (2005) Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas. BMC Clin Pathol 5:6
6. He J, Mokhtari K, Sanson M, Marie Y, Kujas M, Huguet S, Leuraud P, Capelle L, Delattre JY, Poirier J, Hoang-Xuan K (2001) Glioblastomas with an oligodendroglial component: A pathological and molecular study. J Neuropathol Exp Neurol, 60:863-871
7. Houillier C, Lejeune J, Benouaich-Amiel A, Laigle-Donadey F, Criniere E, Mokhtari K, Thillet J, Delattre JY, Hoang-Xuan K, Sanson M (2006) Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer 106:2218-2223
8. Haunerland NH, Spener F (2004) Fatty acid-binding proteins-insights from genetic manipulations. Prog Lipid Res 43:328-49
9. Anthony TE, Mason HA, Gridley T, Fishell G, Heintz N (2005) Brain lipid-binding protein is a direct target of Notch signaling in radial glial cells. Genes Dev 19:1028-1033
10. Sharif A, Legendre P, Prevot V, Allet C, Romao L, Studler JM, Chneiweiss H, Junier MP (2006) Transforming growth factor alpha promotes sequential conversion of mature astrocytes into neural progenitors and stem cells. Oncogene, doi: 10.1038/sj.onc.1210071
11. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157-173